Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5824425 | Clinical Therapeutics | 2016 | 10 Pages |
Abstract
Steady-state levels of selexipag and ACT-333679 after repeated doses of 400 μg selexipag had no influence on the warfarin pharmacodynamic variables. There was no pharmacokinetic interaction between selexipag and warfarin.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Shirin PhD, Kaori BPharm, Hideya PhD, Tim MD, Jasper PhD, PharmD,